PubGene was awarded a new Eurostars project with start date July 2022 together with Da Vinci laboratory solution B.V., Erasmus MC and Evosep Aps. In this project we will develop a technology platform for rapid identification of causative bacterial species in bloodstream infections (BSI/sepcis) by identifying their mechanisms of resistance (MoR). The product solution includes automated sample preparation, measurement technology, protocols for mass-spectrometry (MS) based BSI and MoR identification. As part of the project we will also do a technical and performance validation for a clinical diagnostic product, preparations for clinical validation and out licensing. Fully developed, AntiSeptic will improve BSI treatment response time.